ASAlaser Dentistry: The New Frontier of MLS® Laser Therapy

ASAlaser, since 1983 at the forefront in the development of therapeutic solutions for pain management, in relation to the significant results obtained from research studies conducted at cellular level by its scientific department ASAcampus, has identified in MLS® Laser Therapy an effective response for temporo mandibular disorders (TMD).

Vicenza, Italy, March 25, 2015 --(PR.com)-- A study carried out at international level confirms that temporo-mandibular disorders (TMD) and craniofacial pain are increasing. In addition to be among the leading causes of many diseases such as sleep apnea and sleep disorders, these diseases have also a direct impact on the stomatognathic apparatus, composed of several muscles connected to cranio-mandibular structures, to the rachis, to the shoulder girdle and upper limbs. An abnormal contraction of these muscles has implications for other districts, creating tensions in all those muscles that are part of the functional chains, with postural and cervical consequences. If in the United States the problem has long been recognized and widespread, so much to be subject of functional studies to identify therapeutic methods able to solve individual problems, in Italy the cases are constantly increasing. Finding a therapeutic solution that allows the patient to stem the tide of pain and to recover the best quality of life is therefore a priority. ASAlaser, since 1983 at the forefront in the development of therapeutic solutions for pain management, in relation to the significant results obtained from research studies conducted at cellular level by its scientific department ASAcampus, has identified in MLS® Laser Therapy an effective response. MLS® (Multiwave Locked System), overcoming the limits of traditional laser therapy, guaranteeing short treatments, effective from the first sessions and with long-lasting results, has actually shown to accelerate the resolution of symptoms due to temporo-mandibular disorders. Some American specialists, who use it in their daily practice, confirms it. Dr. Richard Goodfellow of the TMJ and Sleep Therapy Centre of Toronto says, "The laser has impacted our practice significantly; some 80% of chronic pain patients are feeling the results right away," - and Dr. Jim K. Beck from Colorado, a luminary in the treatment of craniofacial pain and TMD disorders emphasizes: "I have been treating TMD for more than 16 years and haven’t seen anything like it." Thanks to these and many other certificates of value, the company has decided to focus on the dental sector, making it one of the points of its development strategy for 2015. "MLS® Laser Therapy in temporo-mandibular disorders and in the treatment of craniofacial pain," explains Lucio Zaghetto, ASAlaser CEO "has been having great success, among others, between the American and Canadian specialists who use it in their daily practice. In addition, our customers are also using it to treat oral cavity problems. In fact, thanks to its anti-inflammatory, analgesic and reparative effects it can be effectively applied after extractions and surgeries on soft tissue, in post-surgery and in implantology. With these results we have chosen to participate in international trade fairs like the TDA Congress in Bangkok on December and the IDS 2015 Congress in Cologne in March."

The German fair, recognized by professionals as the most important in the world for the dental sector, has been for ASAlaser a showcase of excellence. At the company stand, participants have been able to discover the devices of the Mphi D line for MLS® Laser Therapy and to deepen their use in the treatment of specific diseases.

"Our therapeutic solution have," commented Roberto Terruzzi and Giacomo Granozio, ASAlaser Area Managers at the conclusion of the fair in Cologne, "focused on temporo-mandibular, craniofacial pain in addition to intra-oral diseases, has been very well received by professionals, both distributors and end-users. This first participation in one of the most important international trade fairs of the dental field has allowed us to deepen our knowledge about the sector the Mphi D devices are addressed to. Relying on testimonials who are already users of MLS® in dental field in the U.S. has attracted the attention of people we have met, but what make the real difference are the effectiveness and the value of the therapy." Among the 73 companies that have exhibited their laser devices at the fair, only ASA has presented the innovative idea of a therapy with specific devices for the treatment of TMD disorders and cranio-facial pain. An idea that in September the company will also present to FDI in Bangkok, Far East international exposition of the dental sector.
Contact
ASA srl
Tiziana Gobbo
+39 0444 28 92 00
www.asalaser.com
ContactContact
Categories